Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Molecular Therapy. Oncology|March 20, 2026
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506Lesley Schuitmaker, Alexander M A van der Wiel, Natasja G Lieuwes, et al.Cancer Treatment and Research Communications|May 21, 2025
Dietary enrichment with n-3 lc-PUFA-rich fish oil improves preclinical outcome of radiotherapy and anti-PD-L1 combination treatmentAnnemarie J F Westheim, Ludwig J Dubois, Elia Prades-Sagarra, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2015
New ways to image and target tumour hypoxia and its molecular responsesLudwig J Dubois, Raymon Niemans, Simon J A van Kuijk, et al.Molecular Nutrition & Food Research|January 21, 2026
The Effect of Dietary Fiber Compositions on the Therapeutic Outcome of Combined Radio- and Immunotherapy in a Preclinical Cancer ModelAnnemarie J F Westheim, Ludwig J Dubois, Elia Prades-Sagarra, et al.Scientific Reports|October 21, 2022
Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cellsJurgita Matulienė, Gediminas Žvinys, Vytautas Petrauskas, et al.BMC Cancer|June 17, 2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trialRelinde I Y Lieverse, Evert J Van Limbergen, Cary J G Oberije, et al.Molecular Cancer Therapeutics|October 9, 2021
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, et al.Advanced Drug Delivery Reviews|January 18, 2016
Decision support systems for personalized and participative radiation oncologyPhilippe Lambin, Jaap Zindler, Ben G L Vanneste, et al.Pageof 9